nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—Dactinomycin—ocular cancer	0.336	0.492	CbGbCtD
Dabrafenib—ABCG2—Carboplatin—ocular cancer	0.226	0.331	CbGbCtD
Dabrafenib—ABCB1—Dactinomycin—ocular cancer	0.121	0.177	CbGbCtD
Dabrafenib—RAF1—Signaling by EGFR—CDKN1A—ocular cancer	0.000173	0.000545	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—HRAS—ocular cancer	0.000172	0.000543	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.000172	0.000543	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000172	0.000543	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—AKT1—ocular cancer	0.000172	0.000543	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MAML2—ocular cancer	0.000172	0.000542	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—CDKN1A—ocular cancer	0.000172	0.000541	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000171	0.00054	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—CDKN1A—ocular cancer	0.00017	0.000537	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—CCND1—ocular cancer	0.00017	0.000537	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.00017	0.000535	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000169	0.000534	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000169	0.000533	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000169	0.000533	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—HRAS—ocular cancer	0.000168	0.000531	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000167	0.000527	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000165	0.000522	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000164	0.000519	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—HRAS—ocular cancer	0.000164	0.000517	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000164	0.000517	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—E2F3—ocular cancer	0.000163	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000162	0.000511	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—HRAS—ocular cancer	0.00016	0.000505	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—HRAS—ocular cancer	0.000159	0.000502	CbGpPWpGaD
Dabrafenib—RAF1—Integrin-mediated Cell Adhesion—AKT1—ocular cancer	0.000158	0.000499	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000156	0.000492	CbGpPWpGaD
Dabrafenib—BRAF—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000155	0.00049	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—AKT1—ocular cancer	0.000155	0.00049	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—HRAS—ocular cancer	0.000155	0.000489	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000154	0.000487	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SAG—ocular cancer	0.000153	0.000482	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—AKT1—ocular cancer	0.000152	0.00048	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000152	0.000479	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TFDP1—ocular cancer	0.000151	0.000477	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—AKT1—ocular cancer	0.000151	0.000476	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—MYC—ocular cancer	0.000151	0.000475	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00015	0.000474	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TP53—ocular cancer	0.00015	0.000473	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.00015	0.000473	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00015	0.000473	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TFDP1—ocular cancer	0.00015	0.000472	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PSPH—ocular cancer	0.000149	0.000471	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000149	0.000469	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000145	0.000458	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—AKT1—ocular cancer	0.000145	0.000457	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—HRAS—ocular cancer	0.000144	0.000455	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—MDM2—ocular cancer	0.000144	0.000453	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—AKT1—ocular cancer	0.000141	0.000446	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—MDM2—ocular cancer	0.000141	0.000444	CbGpPWpGaD
Dabrafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000137	0.000432	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—AKT1—ocular cancer	0.000137	0.000431	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—HRAS—ocular cancer	0.000136	0.000429	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000136	0.000429	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000136	0.000428	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MDM2—ocular cancer	0.000135	0.000427	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—E2F5—ocular cancer	0.000135	0.000427	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—HRAS—ocular cancer	0.000134	0.000422	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—E2F4—ocular cancer	0.000132	0.000418	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000131	0.000413	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.00013	0.000411	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PSPH—ocular cancer	0.00013	0.00041	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RBL1—ocular cancer	0.00013	0.00041	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00013	0.000409	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—CDKN1B—ocular cancer	0.000129	0.000406	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000128	0.000404	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—HRAS—ocular cancer	0.000128	0.000404	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—HRAS—ocular cancer	0.000127	0.000402	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—AKT1—ocular cancer	0.000127	0.000402	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—CDK2—ocular cancer	0.000127	0.000402	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000127	0.000399	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HDAC1—ocular cancer	0.000126	0.000396	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000124	0.00039	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—ocular cancer	0.000124	0.00039	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CDKN1B—ocular cancer	0.000123	0.00039	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—HRAS—ocular cancer	0.000123	0.000388	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GNA11—ocular cancer	0.000123	0.000388	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CDK4—ocular cancer	0.000123	0.000387	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—HRAS—ocular cancer	0.000122	0.000386	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—HRAS—ocular cancer	0.000122	0.000384	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000122	0.000384	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GNA11—ocular cancer	0.000122	0.000384	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—HRAS—ocular cancer	0.000121	0.000382	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000121	0.000381	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—HRAS—ocular cancer	0.000121	0.00038	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MAML2—ocular cancer	0.00012	0.000379	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—AKT1—ocular cancer	0.00012	0.000379	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MAML2—ocular cancer	0.000119	0.000375	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—CDKN1A—ocular cancer	0.000119	0.000374	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—AKT1—ocular cancer	0.000118	0.000373	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000115	0.000363	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GNAQ—ocular cancer	0.000114	0.00036	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CDKN1A—ocular cancer	0.000114	0.000359	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—HRAS—ocular cancer	0.000114	0.000359	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000113	0.000358	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—HRAS—ocular cancer	0.000113	0.000358	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—HRAS—ocular cancer	0.000113	0.000358	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GNAQ—ocular cancer	0.000113	0.000357	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—AKT1—ocular cancer	0.000113	0.000357	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—E2F3—ocular cancer	0.000113	0.000355	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CDKN2B—ocular cancer	0.000113	0.000355	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—AKT1—ocular cancer	0.000113	0.000355	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—HRAS—ocular cancer	0.000112	0.000355	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—HRAS—ocular cancer	0.000112	0.000352	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000112	0.000352	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000111	0.000351	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—HRAS—ocular cancer	0.000111	0.00035	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—AKT1—ocular cancer	0.000109	0.000343	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EP300—ocular cancer	0.000108	0.000342	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—AKT1—ocular cancer	0.000108	0.000341	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—AKT1—ocular cancer	0.000108	0.000339	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000108	0.000339	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—HRAS—ocular cancer	0.000107	0.000338	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—AKT1—ocular cancer	0.000107	0.000337	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—AKT1—ocular cancer	0.000106	0.000336	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GNA11—ocular cancer	0.000105	0.000331	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TFDP1—ocular cancer	0.000105	0.00033	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—AKT1—ocular cancer	0.000104	0.000329	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000104	0.000328	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000103	0.000324	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.0001	0.000317	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—AKT1—ocular cancer	0.0001	0.000316	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.0001	0.000316	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—AKT1—ocular cancer	0.0001	0.000316	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—AKT1—ocular cancer	9.93e-05	0.000313	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—AKT1—ocular cancer	9.86e-05	0.000311	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—AKT1—ocular cancer	9.84e-05	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—AKT1—ocular cancer	9.8e-05	0.000309	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GNAQ—ocular cancer	9.75e-05	0.000308	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	9.71e-05	0.000306	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—AKT1—ocular cancer	9.46e-05	0.000299	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	9.42e-05	0.000297	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.17e-05	0.000289	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.13e-05	0.000288	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	8.87e-05	0.00028	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HDAC1—ocular cancer	8.79e-05	0.000277	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HDAC1—ocular cancer	8.69e-05	0.000274	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—AKT1—ocular cancer	8.39e-05	0.000265	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.38e-05	0.000264	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAML2—ocular cancer	8.32e-05	0.000262	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GNA11—ocular cancer	8.18e-05	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MDM2—ocular cancer	8.03e-05	0.000253	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PSPH—ocular cancer	8.01e-05	0.000253	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	7.99e-05	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—HRAS—ocular cancer	7.88e-05	0.000249	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDKN2B—ocular cancer	7.88e-05	0.000249	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HRAS—ocular cancer	7.86e-05	0.000248	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CDKN2B—ocular cancer	7.79e-05	0.000246	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	7.73e-05	0.000244	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—HRAS—ocular cancer	7.73e-05	0.000244	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—MDM2—ocular cancer	7.71e-05	0.000243	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GNAQ—ocular cancer	7.6e-05	0.00024	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GNA11—ocular cancer	7.57e-05	0.000239	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HRAS—ocular cancer	7.42e-05	0.000234	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.35e-05	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CDKN1B—ocular cancer	7.33e-05	0.000231	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EP300—ocular cancer	7.29e-05	0.00023	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNA11—ocular cancer	7.26e-05	0.000229	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—E2F1—ocular cancer	7.23e-05	0.000228	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—EP300—ocular cancer	7.15e-05	0.000226	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CDKN1B—ocular cancer	7.04e-05	0.000222	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GNAQ—ocular cancer	7.04e-05	0.000222	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—HRAS—ocular cancer	6.99e-05	0.000221	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—AKT1—ocular cancer	6.82e-05	0.000215	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CDKN1A—ocular cancer	6.77e-05	0.000213	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNAQ—ocular cancer	6.75e-05	0.000213	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—AKT1—ocular cancer	6.55e-05	0.000207	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CDKN1A—ocular cancer	6.5e-05	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EP300—ocular cancer	6.44e-05	0.000203	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.41e-05	0.000202	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.39e-05	0.000202	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—ocular cancer	6.34e-05	0.0002	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MDM2—ocular cancer	6.24e-05	0.000197	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—ocular cancer	6.22e-05	0.000196	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.13e-05	0.000193	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HDAC1—ocular cancer	6.08e-05	0.000192	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CDKN1B—ocular cancer	5.7e-05	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDKN2B—ocular cancer	5.45e-05	0.000172	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.26e-05	0.000166	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CDKN1A—ocular cancer	5.26e-05	0.000166	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—ocular cancer	5.12e-05	0.000161	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EP300—ocular cancer	5.01e-05	0.000158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—E2F1—ocular cancer	5e-05	0.000158	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—HRAS—ocular cancer	4.99e-05	0.000157	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HRAS—ocular cancer	4.9e-05	0.000154	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GNA11—ocular cancer	4.7e-05	0.000148	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MDM2—ocular cancer	4.68e-05	0.000148	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.44e-05	0.00014	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—HRAS—ocular cancer	4.41e-05	0.000139	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—AKT1—ocular cancer	4.41e-05	0.000139	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MDM2—ocular cancer	4.37e-05	0.000138	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GNAQ—ocular cancer	4.37e-05	0.000138	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MYC—ocular cancer	4.36e-05	0.000138	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—ocular cancer	4.35e-05	0.000137	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—AKT1—ocular cancer	4.32e-05	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MDM2—ocular cancer	4.32e-05	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDKN1B—ocular cancer	4.27e-05	0.000135	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HRAS—ocular cancer	4.23e-05	0.000133	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GNA11—ocular cancer	4.09e-05	0.000129	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EP300—ocular cancer	4.07e-05	0.000128	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDKN1B—ocular cancer	3.99e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CDKN1B—ocular cancer	3.94e-05	0.000124	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDKN1A—ocular cancer	3.94e-05	0.000124	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—AKT1—ocular cancer	3.89e-05	0.000123	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCND1—ocular cancer	3.81e-05	0.00012	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GNAQ—ocular cancer	3.81e-05	0.00012	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EP300—ocular cancer	3.75e-05	0.000118	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—AKT1—ocular cancer	3.74e-05	0.000118	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDKN1A—ocular cancer	3.68e-05	0.000116	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CDKN1A—ocular cancer	3.64e-05	0.000115	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.53e-05	0.000111	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EP300—ocular cancer	3.51e-05	0.000111	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EP300—ocular cancer	3.46e-05	0.000109	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HRAS—ocular cancer	3.43e-05	0.000108	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MYC—ocular cancer	3.05e-05	9.63e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—ocular cancer	3.05e-05	9.61e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—AKT1—ocular cancer	3.02e-05	9.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MDM2—ocular cancer	3.02e-05	9.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MYC—ocular cancer	3.02e-05	9.52e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—ocular cancer	3.01e-05	9.5e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HRAS—ocular cancer	2.81e-05	8.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDKN1B—ocular cancer	2.76e-05	8.71e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EP300—ocular cancer	2.73e-05	8.62e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCND1—ocular cancer	2.63e-05	8.31e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HRAS—ocular cancer	2.57e-05	8.1e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDKN1A—ocular cancer	2.55e-05	8.04e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EP300—ocular cancer	2.53e-05	7.98e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GNA11—ocular cancer	2.52e-05	7.96e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—ocular cancer	2.51e-05	7.91e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AKT1—ocular cancer	2.48e-05	7.82e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—AKT1—ocular cancer	2.46e-05	7.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EP300—ocular cancer	2.43e-05	7.65e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HRAS—ocular cancer	2.4e-05	7.57e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HRAS—ocular cancer	2.37e-05	7.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GNAQ—ocular cancer	2.34e-05	7.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—AKT1—ocular cancer	2.27e-05	7.15e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AKT1—ocular cancer	2.12e-05	6.68e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MYC—ocular cancer	2.11e-05	6.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—ocular cancer	2.11e-05	6.65e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—AKT1—ocular cancer	2.09e-05	6.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—ocular cancer	1.74e-05	5.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HRAS—ocular cancer	1.66e-05	5.24e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AKT1—ocular cancer	1.65e-05	5.21e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EP300—ocular cancer	1.57e-05	4.95e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AKT1—ocular cancer	1.53e-05	4.82e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AKT1—ocular cancer	1.47e-05	4.62e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EP300—ocular cancer	1.37e-05	4.31e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AKT1—ocular cancer	9.49e-06	2.99e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EP300—ocular cancer	8.43e-06	2.66e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AKT1—ocular cancer	8.27e-06	2.61e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AKT1—ocular cancer	5.09e-06	1.61e-05	CbGpPWpGaD
